Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in NUVB — Nuvation Bio Inc.

CIK 1179392 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,090,963
-$4,423,778 QoQ
Shares Held
1,248,409
-53.5% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 242 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. NUVB ranks #99 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in NUVB

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,090,963 1,248,409
2026-03-31 $11,514,741 2,684,089
2025-12-31 $6,594,067 735,945
2025-09-30 $8,797,009 2,377,570
2025-06-30 $2,368,729 1,214,733
2025-03-31 $1,209,785 687,378
2024-12-31 $3,062,340 1,151,256
2024-09-30 $2,622,807 1,145,331
2024-06-30 $3,123,818 1,069,801
2024-03-31 $4,200,767 1,154,057
2023-12-31 $2,283,677 1,512,369
2023-09-30 $833,827 622,259
2023-06-30 $1,023,629 568,683
2023-03-31 $750,411 452,055
2022-12-31 $1,328,400 691,875
2022-09-30 $1,189,401 530,983
2022-06-30 $1,136,572 350,794
2022-03-31 $527,783 100,339